Skip to main content
Log in

Dihydropyrimidine dehydrogenase in normal and malignant endometrium: relationship with cell proliferation and thymidine phosphorylase

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Dihydropyrimidine dehydrogenase (DPD) is a pyrimidine salvage enzyme responsible for degradation of thymine, which is produced from thymidine by thymidine phosphorylase (TP). Our purpose was to determine the relationship between DPD, cell proliferation and TP expression in human endometrium. We examined DPD gene expression using reverse transcription-polymerase chain reaction, DPD protein levels using enzyme-linked immunosorbent assay, and DPD protein localization using immunohistochemistry in 58 normal endometria and 28 endometrial cancers. DPD gene expression was then related to the proliferating cell nuclear antigen index and to TP gene expression. DPD gene expression, which was correlated with DPD protein level, was relatively stable throughout various menstrual phases but was significantly elevated in postmenopausal status. It was significantly lower in endometrial cancer than in normal endometrium. Localization analysis revealed that DPD protein was located primarily in epithelial cells, but was also present in stromal cells. DPD gene expression correlated inversely with the PCNA index. TP gene expression pattern contrasted with that of DPD in postmenopausal and malignant endometrium. A high ratio of TP to DPD gene expression was significantly more frequent in endometrial cancer than in normal endometrium in any menstrual phase. DPD may act cooperatively with TP to affect cell function by maintaining the pyrimidine nucleotide pool balance in normal and malignant endometrium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.
Fig. 7.

Similar content being viewed by others

References

  1. Brown NS, Bicknell R (1998) Thymidine phosphorylase, 2-deoxy-d-ribose and angiogenesis. Biochem J 334:1–8

    CAS  PubMed  Google Scholar 

  2. Canellakis ES (1956) Pyrimidine metabolism-enzymatic pathways of uracil and thymidine degradation. J Biol Chem 221:315–322

    CAS  Google Scholar 

  3. Eda H, Fujimoto K, Watanabe S, Ura M, Hino A, Tanaka Y, Wada K, Ishitsuka H (1993) Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chemother Pharmacol 32:333–338

    CAS  PubMed  Google Scholar 

  4. Fink RM, Fink K, Henderson RB (1955) Beta-amino acid formation by tissue slices incubated with pyrimidines. J Biol Chem 201:349–355

    Google Scholar 

  5. Fujimoto J, Ichigo S, Sakaguchi H, Hirose R, Tamaya T (1998) Expression of platelet-derived endothelial cell growth factor and its mRNA in uterine endometrium during the menstrual cycle. Mol Hum Reprod 4:509–513

    Article  CAS  PubMed  Google Scholar 

  6. Fujiwaki R, Hata K, Iida K, Koike M, Miyazaki K (1998) Immunohistochemical expression of thymidine phosphorylase in human endometrial cancer. Gynecol Oncol 68:247–252

    Article  CAS  PubMed  Google Scholar 

  7. Fujiwaki R, Hata K, Iida K, Maede Y, Koike M, Miyazaki K (1999) Thymidine phosphorylase expression in progression of cervical cancer: correlation with microvessel count, proliferating cell nuclear antigen, and apoptosis. J Clin Pathol 52:598–603

    CAS  PubMed  Google Scholar 

  8. Fujiwaki R, Hata K, Nakayama K, Fukumoto M, Miyazaki K (2000) Gene expression for dihydropyrimidine dehydrogenase and thymidine phosphorylase influences outcome in epithelial ovarian cancer. J Clin Oncol 18:3946–3951

    CAS  PubMed  Google Scholar 

  9. Fujiwaki R, Hata K, Nakayama K, Moriyama M, Iwanari O, Katabuchi H, Okamura H, Sakai E, Miyazaki K (2002) Thymidine kinase in epithelial ovarian cancer: relationship with the other pyrimidine pathway enzymes. Int J Cancer 99:328–335

    Article  PubMed  Google Scholar 

  10. Griffiths L, Dachs GU, Bicknell R, Harris AL, Stratford IJ (1997) The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res 57:570–572

    CAS  PubMed  Google Scholar 

  11. Ho DH, Townsend L, Luna MA, Bodey GP (1986) Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrate. Anticancer Res 6:781–784

    CAS  PubMed  Google Scholar 

  12. Iltzsch MH, el Kouni MH, Cha S (1985) Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry 24:6799–6807

    CAS  PubMed  Google Scholar 

  13. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin CH (1989) Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338:557–562

    CAS  PubMed  Google Scholar 

  14. Ishikawa T, Sekiguchi F, Fukase Y, Sawada N, Ishitsuka H (1998) Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts. Cancer Res 58:685–690

    CAS  PubMed  Google Scholar 

  15. Jiang W, Lu Z, He Y, Diasio RB (1997) Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: implication in 5-fluorouracil-based chemotherapy. Clin Cancer Res 3:395–399

    Google Scholar 

  16. Kitazono M, Takebayashi Y, Ishitsuka K, Takao S, Tani A, Furukawa T, Miyadera K, Yamada Y, Aikou T, Akiyama S (1998) Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase. Biochem Biophys Res Commun 253:797–803

    Article  CAS  PubMed  Google Scholar 

  17. McLeod HL, Sludden J, Murray GI, Keenan RA, Davidson AI, Park K, Koruth M, Cassidy J (1998) Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours. Br J Cancer 77:461–465

    CAS  PubMed  Google Scholar 

  18. Moghaddam A, Zhang HT, Fan TP, Hu DE, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL, Bicknell R (1995) Thymidine phosphorylase in angiogenic and promotes tumor growth. Proc Natl Acad U S A 92:998–1002

    CAS  Google Scholar 

  19. Mori K, Hasegawa M, Nishida M, Toma H, Fukuda M, Kubota T, Nagasue N, Yamana H, Hirakawa-YS Chung K, Ikeda T, Takasaki K, Oka M, Kameyama M, Toi M, Fujii H, Kitamura M, Murai M, Sasaki H, Ozono S, Makuuchi H, Shimada Y, Onishi Y, Aoyagi S, Mizutani K, Ogawa M, Nakao A, Kinoshita H, Tono T, Imamoto H, Nakashima Y, Manabe T (2000) Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues. Int J Oncol 17:33–38

    Google Scholar 

  20. Noyes RW, Hertig AT, Rock J (1955) Dating the endometrial biopsy. Fertil Steril 1:3–25

    Google Scholar 

  21. Naguib FN, el Kouni MH, Cha S (1985) Enzymes of uracil catabolism in normal and neoplastic human tissues. Cancer Res 45:5405–5412

    CAS  PubMed  Google Scholar 

  22. Okabe H, Arakawa K, Takechi S, Fukushima M (2000) Expression of recombinant human dihydropyrimidine dehydrogenase and its application to the preparation of anti-DPD antibodies for immunohistochemical detection. Jpn J Cancer Chemother 27:891–898

    CAS  Google Scholar 

  23. Osuga Y, Toyoshima H, Mitsuhashi N, Taketani Y (1995) The presence of platelet-derived endothelial cell growth factor in human endometrium and its characteristic expression during the menstrual cycle and early gestational period. Hum Reprod 10:989–993

    CAS  PubMed  Google Scholar 

  24. Queener SF, Morris HP, Weber G (1971) Dihydrouracil dehydrogenase activity in normal, differentiating, and regenerating liver and hepatomas. Cancer Res 31:1004–1009

    CAS  PubMed  Google Scholar 

  25. Terashima M, Fujiwara H, Takagane A, Abe K, Araya M, Irinoda T, Yonezawa H, Nakaya T, Oyama K, Takahashi M, Saito K (2002) Role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in tumour progression and sensitivity to doxifluridine in gastric cancer patients. Eur J Cancer 38:2375–2381

    Article  CAS  PubMed  Google Scholar 

  26. Tuchman M, Ramnaraine ML, O'Dea RF (1985) Effects of uridine and thymidine on the degradation of 5-fluorouracil, uracil, and thymine by rat liver dihydropyrimidine dehydrogenase. Cancer Res 45:5553–5556

    CAS  PubMed  Google Scholar 

  27. Tuchman M, O'Dea RF, Ramnaraine ML, Mirkin BL (1988) Pyrimidine base degradation in cultured murine C-1300 neuroblastoma cells and in situ tumors. J Clin Invest 81:425–430

    CAS  PubMed  Google Scholar 

  28. Zhang L, Mackenzie IZ, Rees MC, Bicknell R (1997) Regulation of the expression of the angiogenic enzyme platelet-derived endothelial cell growth factor/thymidine phosphorylase in endometrial isolates by ovarian steroids and cytokines. Endocrinology 138:4921–4930

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by a Grant-in-Aid (No. 13770917) from the Japan Society for the Promotion of Science. We thank Mr. Mikio Koike, Laboratory Medicine and Central Clinical Laboratory, Shimane Medical University, for providing paraffin-embedded tissues and Miss Taeko Yamada, Department of Obstetrics and Gynecology, Shimane Medical University, for her management of medical records.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ritsuto Fujiwaki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fujiwaki, R., Iida, K., Nakayama, K. et al. Dihydropyrimidine dehydrogenase in normal and malignant endometrium: relationship with cell proliferation and thymidine phosphorylase. Virchows Arch 443, 672–677 (2003). https://doi.org/10.1007/s00428-003-0866-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-003-0866-3

Keywords

Navigation